Catálogos >
ANT Neuro >
visor2™ leaflet: Psychiatric disorders

visor2™ leaflet: Psychiatric disorders
1 / 2Páginas

Excertos do catálogo

visor2™ leaflet: Psychiatric disorders - 1

Treatment of Psychiatric Disorders The visor2 system is not available for sale in all countries, please refer to the associated visor2 specification documents or contact you local representative for details. https://www.ant-neuro.com/contact-us

Abrir o catálogo na página 1

visor2™ leaflet: Psychiatric disorders - 2

Treatment of Psychiatric Disorders One-third of adults with Major Depressive Disorder (MDD) have experienced persistent symptoms which do not respond to pharmacological treatment. Navigated repeated TMS (rTMS) has been approved by the U.S. FDA and several regulatory agencies around the world as a non-invasive treatment for Major Depressive Disorder. rTMS has been proven beneficial for treatment-resistant MDD patients who had not previously responded to any antidepressant medication. More recently, long-term gains have been observed in MDD patients receiving rTMS treatment followed by...

Abrir o catálogo na página 2